Searched over 200M research papers
10 papers analyzed
These studies suggest that anemia is characterized by low hemoglobin levels, with various diagnostic methods and treatments available, and its impact varies by age, underlying conditions, and specific patient populations.
20 papers analyzed
Anemia is a widespread health issue characterized by low hemoglobin (Hb) levels, which impairs the blood's ability to carry oxygen. According to the World Health Organization (WHO), anemia is defined as Hb levels below 13.0 g/dL in men and 12.0 g/dL in women . These thresholds, established in 1968, are still widely used, although variations exist based on age, sex, and ethnicity .
The prevalence of anemia increases with age, particularly in the elderly. In this demographic, anemia is often mild, with Hb levels ranging from 10 to 12 g/dL. Aging is associated with dysregulation of pro-inflammatory cytokines, such as interleukin-6 (IL-6), which can inhibit erythropoiesis and contribute to anemia. This condition is linked to various complications, including increased mortality, cardiovascular disease, cognitive dysfunction, and reduced quality of life.
Anemia is prevalent in patients with acute coronary syndrome (ACS) and chronic diseases like inflammatory bowel disease (IBD) and chronic kidney disease. In ACS, anemia on admission is found in 10% to 43% of patients, and hospital-acquired anemia (HAA) can develop in up to 57% of cases. Both conditions are associated with worse outcomes and increased mortality. In IBD, anemia prevalence ranges from 8.8% to 73.7%, with severe anemia defined as Hb levels below 10 g/dL.
Recent advancements have led to the development of non-invasive methods for monitoring Hb levels. Smartphone-based applications, such as those using spectroscopy and image analysis of fingernail beds, offer a promising alternative to traditional blood tests. These apps can detect anemia with high accuracy and sensitivity, making them suitable for at-home diagnosis and monitoring .
Understanding the underlying causes of anemia is crucial for effective treatment. Anemia can result from nutritional deficiencies (iron, folate, vitamin B12), chronic diseases, or unexplained factors such as bone marrow resistance to erythropoietin . Accurate diagnosis and appropriate interventions, including iron supplementation and erythropoiesis-stimulating agents, are essential for managing anemia and improving patient outcomes.
Anemia, defined by low hemoglobin levels, is a significant health concern with various underlying causes and associated risks. Accurate diagnosis and innovative monitoring methods are essential for effective management and improving the quality of life for affected individuals. Further research is needed to refine diagnostic criteria and develop targeted interventions for different patient populations.
Most relevant research papers on this topic